{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:00:11Z","timestamp":1790226011576,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1102732"],"award-info":[{"award-number":["1102732"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1070586"],"award-info":[{"award-number":["1070586"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1122596"],"award-info":[{"award-number":["1122596"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1150102"],"award-info":[{"award-number":["1150102"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1023222"],"award-info":[{"award-number":["1023222"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001249","name":"University of Tasmania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001249","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Knee osteoarthritis (OA) is a common and important cause of pain and disability, but interventions aimed at modifying structures visible on imaging have been disappointing. While OA affects the whole joint, synovitis and effusion have been recognised as having a role in the pathogenesis of OA. Krill oil reduces knee pain and systemic inflammation and could be used for targeting inflammatory mechanisms of OA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods\/design<\/jats:title>\n                    <jats:p>We will recruit 260 patients with clinical knee OA, significant knee pain and effusion-synovitis present on MRI in five Australian cities (Hobart, Melbourne, Sydney, Adelaide and Perth). These patients will be randomly allocated to the two arms of the study, receiving 2\u2009g\/day krill oil or inert placebo daily for 6\u2009months. MRI of the study knee will be performed at screening and after 6\u2009months. Knee symptoms, function and MRI structural abnormalities will be assessed using validated methods. Safety data will be recorded. Primary outcomes are absolute change in knee pain (assessed by visual analog score) and change in size of knee effusion-synovitis over 24\u2009weeks. Secondary outcomes include improvement in knee pain over 4, 8, 12, 16 and 20\u2009weeks. The primary analyses will be intention-to-treat analyses of primary and secondary outcomes. Per protocol analyses adjusting for missing data and for treatment compliance will be performed as the secondary analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This study will provide high-quality evidence to assess whether krill oil 2\u2009g\/day reduces pain and effusion-synovitis size in older adults with clinical knee OA and knee effusion-synovitis. If krill oil is effective and confirmed to be safe, we will provide compelling evidence that krill oil improves pain and function, changes disease trajectory and slows disease progression in OA. Given the lack of\n                      <jats:italic>approved therapies<\/jats:italic>\n                      for slowing disease progression in OA, and moderate cost of krill oil, these findings will be readily translated into clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Australian New Zealand Clinical Trials Registry,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=370492\">ACTRN12616000726459<\/jats:ext-link>\n                      . Registered on 02 June 2016.\n                    <\/jats:p>\n                    <jats:p>Universal Trial Number (UTN) U1111\u20131181-7087.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-019-3915-1","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T11:14:51Z","timestamp":1579000491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["KARAOKE: Krill oil versus placebo in the treatment of knee osteoarthritis: protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4336-0095","authenticated-orcid":false,"given":"L. L.","family":"Laslett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Wluka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. I.","family":"Keen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Otahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"Cicuttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"3915_CR1","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197\u2013223.","journal-title":"Lancet"},{"key":"3915_CR2","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1323\u201330.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/1529-0131(200010)13:5<312::AID-ANR11>3.0.CO;2-L","volume":"13","author":"D Tallon","year":"2000","unstructured":"Tallon D, Chard J, Dieppe P. Exploring the priorities of patients with osteoarthritis of the knee. Arthritis Care Res. 2000;13:312\u20139.","journal-title":"Arthritis Care Res"},{"key":"3915_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/rheumatology\/keu332","volume":"54","author":"PG Conaghan","year":"2015","unstructured":"Conaghan PG, Peloso PM, Everett SV, Rajagopalan S, Black CM, Mavros P, Arden NK, Phillips CJ, Rannou F, van de Laar MA, et al. Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies. Rheumatology (Oxford). 2015;54:270\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"3915_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.joca.2010.09.013","volume":"19","author":"NE Lane","year":"2011","unstructured":"Lane NE, Brandt K, Hawker G, Peeva E, Schreyer E, Tsuji W, Hochberg MC. OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthr Cartil. 2011;19:478\u201382.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2217\/ijr.13.19","volume":"8","author":"G Jones","year":"2013","unstructured":"Jones G. Sources of pain in osteoarthritis: Implications for therapy. Int J Clin Rheumatol. 2013;8:335\u201345.","journal-title":"Int J Clin Rheumatol"},{"key":"3915_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/art.1780400419","volume":"40","author":"TD Spector","year":"1997","unstructured":"Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997;40:723\u20137.","journal-title":"Arthritis Rheum"},{"key":"3915_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","volume":"51","author":"CR Scanzello","year":"2012","unstructured":"Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51:249\u201357.","journal-title":"Bone"},{"key":"3915_CR9","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.joca.2017.08.009","volume":"25","author":"LA Deveza","year":"2017","unstructured":"Deveza LA, Melo L, Yamato TP, Mills K, Ravi V, Hunter DJ. Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review. Osteoarthr Cartil. 2017;25:1926\u201341.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/annrheumdis-2013-204494","volume":"74","author":"X Jin","year":"2015","unstructured":"Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, Ding C. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:703\u201310.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.joca.2006.10.010","volume":"15","author":"AD Pearle","year":"2007","unstructured":"Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, Sculco TP, Crow MK. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthr Cartil. 2007;15:516\u201323.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/annrheumdis-2011-201047","volume":"72","author":"OP Stannus","year":"2013","unstructured":"Stannus OP, Jones G, Blizzard L, Cicuttini FM, Ding C. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis. 2013;72:535\u201340.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR13","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/ar2380","volume":"10","author":"FS Hanna","year":"2008","unstructured":"Hanna FS, Bell RJ, Cicuttini FM, Davison SL, Wluka AE, Davis SR. High sensitivity C-reactive protein is associated with lower tibial cartilage volume but not lower patella cartilage volume in healthy women at mid-life. Arthritis Res Ther. 2008;10:R27.","journal-title":"Arthritis Res Ther"},{"key":"3915_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/ard.59.1.71","volume":"59","author":"M Sharif","year":"2000","unstructured":"Sharif M, Shepstone L, Elson CJ, Dieppe PA, Kirwan JR. Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis. 2000;59:71\u20134.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/ard.2010.131904","volume":"70","author":"E Yusuf","year":"2011","unstructured":"Yusuf E, Kortekaas MC, Watt I, Huizinga TW, Kloppenburg M. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Ann Rheum Dis. 2011;70:60\u20137.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR16","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1136\/ard.2006.067470","volume":"66","author":"CL Hill","year":"2007","unstructured":"Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, Gale D, Grainger A, Conaghan P, Felson DT. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis. 2007;66:1599\u2013603.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/art.30148","volume":"63","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Nevitt M, Niu J, Lewis C, Torner J, Guermazi A, Roemer F, McCulloch C, Felson DT. Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum. 2011;63:691\u20139.","journal-title":"Arthritis Rheum"},{"key":"3915_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3899\/jrheum.150355","volume":"43","author":"X Wang","year":"2016","unstructured":"Wang X, Jin X, Han W, Cao Y, Halliday A, Blizzard L, Pan F, Antony B, Cicuttini F, Jones G, Ding C. Cross-sectional and longitudinal associations between knee joint effusion synovitis and knee pain in older adults. J Rheumatol. 2016;43:121\u201330.","journal-title":"J Rheumatol"},{"issue":"3","key":"3915_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/annrheumdis-2014-206676","volume":"75","author":"Xia Wang","year":"2014","unstructured":"Wang X, Blizzard L, Halliday A, Han W, Jin X, Cicuttini F, Jones G, Ding C. Association between MRI-detected knee joint regional effusion-synovitis and structural changes in older adults: a cohort study. Ann Rheum Dis. 2014;75:519-525.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"3915_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/ard.2008.099564","volume":"69","author":"PG Conaghan","year":"2010","unstructured":"Conaghan PG, D'Agostino MA, Le Bars M, Baron G, Schmidely N, Wakefield R, Ravaud P, Grassi W, Martin-Mola E, So A, et al. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis. 2010;69:644\u20137.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3899\/jrheum.130199","volume":"41","author":"A Abou-Raya","year":"2014","unstructured":"Abou-Raya A, Abou-Raya S, Khadrawi T, Helmii M. Effect of low-dose oral prednisolone on symptoms and systemic inflammation in older adults with moderate to severe knee osteoarthritis: a randomized placebo-controlled trial. J Rheumatol. 2014;41:53\u20139.","journal-title":"J Rheumatol"},{"key":"3915_CR22","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.joca.2018.02.899","volume":"26","author":"D Aitken","year":"2018","unstructured":"Aitken D, Laslett LL, Pan F, Haugen IK, Otahal P, Bellamy N, Bird P, Jones G. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial. Osteoarthr Cartil. 2018;26:880\u20137.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pain.2007.01.020","volume":"129","author":"RJ Goldberg","year":"2007","unstructured":"Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain. 2007;129:210\u201323.","journal-title":"Pain"},{"key":"3915_CR24","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/0895-4356(95)00028-3","volume":"48","author":"PR Fortin","year":"1995","unstructured":"Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, Sperling RI. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol. 1995;48:1379\u201390.","journal-title":"J Clin Epidemiol"},{"key":"3915_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.arcmed.2012.06.011","volume":"43","author":"YH Lee","year":"2012","unstructured":"Lee YH, Bae SC, Song GG. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res. 2012;43:356\u201362.","journal-title":"Arch Med Res"},{"key":"3915_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/annrheumdis-2013-204145","volume":"74","author":"SM Proudman","year":"2015","unstructured":"Proudman SM, James MJ, Spargo LD, Metcalf RG, Sullivan TR, Rischmueller M, Flabouris K, Wechalekar MD, Lee AT, Cleland LG. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Ann Rheum Dis. 2015;74:89\u201395.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.joca.2012.01.021","volume":"20","author":"KR Baker","year":"2012","unstructured":"Baker KR, Matthan NR, Lichtenstein AH, Niu J, Guermazi A, Roemer F, Grainger A, Nevitt MC, Clancy M, Lewis CE, et al. Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee: the MOST study. Osteoarthr Cartil. 2012;20:382\u20137.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"3915_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/nu9010042","volume":"9","author":"Ninna Senftleber","year":"2017","unstructured":"Senftleber NK, Nielsen SM, Andersen JR, Bliddal H, Tarp S, Lauritzen L, Furst DE, Suarez-Almazor ME, Lyddiatt A, Christensen R. Marine oil supplements for arthritis pain: a systematic review and meta-analysis of randomized trials. Nutrients. 2017;9:E42.","journal-title":"Nutrients"},{"key":"3915_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/annrheumdis-2014-207169","volume":"75","author":"CL Hill","year":"2016","unstructured":"Hill CL, March LM, Aitken D, Lester SE, Battersby R, Hynes K, Fedorova T, Proudman SM, James M, Cleland LG, Jones G. Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. Ann Rheum Dis. 2016;75:23\u20139.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1753-4887.2007.tb00283.x","volume":"65","author":"JC Tou","year":"2007","unstructured":"Tou JC, Jaczynski J, Chen YC. Krill for human consumption: nutritional value and potential health benefits. Nutr Rev. 2007;65:63\u201377.","journal-title":"Nutr Rev"},{"key":"3915_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11745-010-3490-4","volume":"46","author":"SM Ulven","year":"2011","unstructured":"Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011;46:37\u201346.","journal-title":"Lipids"},{"key":"3915_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2474-11-136","volume":"11","author":"M Ierna","year":"2010","unstructured":"Ierna M, Kerr A, Scales H, Berge K, Griinari M. Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. BMC Musculoskelet Disord. 2010;11:136.","journal-title":"BMC Musculoskelet Disord"},{"key":"3915_CR33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00394-012-0441-2","volume":"52","author":"NF Vigerust","year":"2013","unstructured":"Vigerust NF, Bjorndal B, Bohov P, Brattelid T, Svardal A, Berge RK. Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-alpha. Eur J Nutr. 2013;52:1315\u201325.","journal-title":"Eur J Nutr"},{"key":"3915_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/07315724.2007.10719584","volume":"26","author":"L Deutsch","year":"2007","unstructured":"Deutsch L. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J Am Coll Nutr. 2007;26:39\u201348.","journal-title":"J Am Coll Nutr"},{"key":"3915_CR35","doi-asserted-by":"publisher","first-page":"e0162769","DOI":"10.1371\/journal.pone.0162769","volume":"11","author":"Y Suzuki","year":"2016","unstructured":"Suzuki Y, Fukushima M, Sakuraba K, Sawaki K, Sekigawa K. Krill oil improves mild knee joint pain: A randomized control trial. PLoS One. 2016;11:e0162769.","journal-title":"PLoS One"},{"key":"3915_CR36","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","volume":"152","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726\u201332.","journal-title":"Ann Intern Med"},{"key":"3915_CR37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039\u201349.","journal-title":"Arthritis Rheum"},{"key":"3915_CR38","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3899\/jrheum.161596","volume":"44","author":"X Wang","year":"2017","unstructured":"Wang X, Jin X, Blizzard L, Antony B, Han W, Zhu Z, Cicuttini F, Wluka AE, Winzenberg T, Jones G, Ding C. Associations between knee effusion-synovitis and joint structural changes in patients with knee osteoarthritis. J Rheumatol. 2017;44:1644\u201351.","journal-title":"J Rheumatol"},{"key":"3915_CR39","first-page":"3","volume":"3","author":"RD Altman","year":"1995","unstructured":"Altman RD, Hochberg M, Murphy WA Jr, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthr Cartil. 1995;3:3\u201370.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/cpt1974155443","volume":"15","author":"DR Taves","year":"1974","unstructured":"Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974;15:443\u201353.","journal-title":"Clin Pharmacol Ther"},{"key":"3915_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","volume":"12","author":"T Pham","year":"2004","unstructured":"Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, Simon L, Strand V, Woodworth T, Dougados M. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthr Cartil. 2004;12:389\u201399.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR42","first-page":"1833","volume":"15","author":"N Bellamy","year":"1988","unstructured":"Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833\u201340.","journal-title":"J Rheumatol"},{"key":"3915_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2474-11-80","volume":"11","author":"P Kersten","year":"2010","unstructured":"Kersten P, White PJ. Tennant A: The visual analogue WOMAC 3.0 scale--internal validity and responsiveness of the VAS version. BMC Musculoskelet Disord. 2010;11:80.","journal-title":"BMC Musculoskelet Disord"},{"key":"3915_CR44","unstructured":"Bellamy N. WOMAC Osteoarthritis Index User Guide. Version VII. Brisbane, Australia; 2005. http:\/\/www.womac.org\/womac\/womac_userguide.htm"},{"key":"3915_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/annrheumdis-2014-206676","volume":"75","author":"X Wang","year":"2016","unstructured":"Wang X, Blizzard L, Halliday A, Han W, Jin X, Cicuttini F, Jones G, Ding C. Association between MRI-detected knee joint regional effusion-synovitis and structural changes in older adults: a cohort study. Ann Rheum Dis. 2016;75:519\u201325.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR46","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.joca.2017.02.804","volume":"25","author":"X Wang","year":"2017","unstructured":"Wang X, Cicuttini F, Jin X, Wluka AE, Han W, Zhu Z, Blizzard L, Antony B, Winzenberg T, Jones G, Ding C. Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis. Osteoarthr Cartil. 2017;25:1304\u201312.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR47","doi-asserted-by":"publisher","first-page":"R222","DOI":"10.1186\/ar3209","volume":"12","author":"D Dor\u00e9","year":"2010","unstructured":"Dor\u00e9 D, Martens A, Quinn S, Ding C, Winzenberg T, Zhai G, Pelletier JP, Martel-Pelletier J, Abram F, Cicuttini F, Jones G. Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults. Arthritis Res Ther. 2010;12:R222.","journal-title":"Arthritis Res Ther"},{"key":"3915_CR48","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","volume":"71","author":"LL Laslett","year":"2012","unstructured":"Laslett LL, Dor\u00e9 DA, Quinn SJ, Boon P, Ryan E, Winzenberg TM, Jones G. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis. 2012;71:1322\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR49","doi-asserted-by":"publisher","first-page":"R223","DOI":"10.1186\/ar3210","volume":"12","author":"D Dor\u00e9","year":"2010","unstructured":"Dor\u00e9 D, Quinn S, Ding C, Winzenberg T, Zhai G, Cicuttini F, Jones G. Natural history and clinical significance of MRI-detected bone marrow lesions at the knee: a prospective study in community dwelling older adults. Arthritis Res Ther. 2010;12:R223.","journal-title":"Arthritis Res Ther"},{"key":"3915_CR50","first-page":"2485","volume":"32","author":"RJ Wakefield","year":"2005","unstructured":"Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32:2485\u20137.","journal-title":"J Rheumatol"},{"key":"3915_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpain.2005.02.003","volume":"10","author":"R Rolke","year":"2006","unstructured":"Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain. 2006;10:77\u201388.","journal-title":"Eur J Pain"},{"key":"3915_CR52","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.joca.2012.07.019","volume":"20","author":"LL Laslett","year":"2012","unstructured":"Laslett LL, Quinn SJ, Darian-Smith E, Kwok M, Fedorova T, Korner H, Steels E, March L, Jones G. Treatment with 4Jointz reduces knee pain over 12 weeks of treatment in patients with clinical knee osteoarthritis: a randomised controlled trial. Osteoarthr Cartil. 2012;20:1209\u201316.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR53","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/1529-0131(200011)43:11<2543::AID-ANR23>3.0.CO;2-K","volume":"43","author":"G Jones","year":"2000","unstructured":"Jones G, Glisson M, Hynes K, Cicuttini F. Sex and site differences in cartilage development: a possible explanation for variations in knee osteoarthritis in later life. Arthritis Rheum. 2000;43:2543\u20139.","journal-title":"Arthritis Rheum"},{"key":"3915_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.joca.2007.12.015","volume":"16","author":"GA Hawker","year":"2008","unstructured":"Hawker GA, Davis AM, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Katz JN, Dieppe P. Development and preliminary psychometric testing of a new OA pain measure--an OARSI\/OMERACT initiative. Osteoarthr Cartil. 2008;16:409\u201314.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR55","unstructured":"Measure of Intermittent and Constant Osteoarthritis Pain: ICOAP User\u2019s Guide [https:\/\/www.oarsi.org\/sites\/default\/files\/docs\/2013\/icoap_users_guide_07072010.pdf]. Accessed 13 Nov 2018."},{"key":"3915_CR56","unstructured":"AQoL-6D [http:\/\/www.aqol.com.au\/aqolquestionnaires\/56.html]. Accessed 13 Nov 2018."},{"key":"3915_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1477-7525-10-38","volume":"10","author":"JR Richardson","year":"2012","unstructured":"Richardson JR, Peacock SJ, Hawthorne G, Iezzi A, Elsworth G, Day NA. Construction of the descriptive system for the Assessment of Quality of Life AQoL-6D utility instrument. Health Qual Life Outcomes. 2012;10:38.","journal-title":"Health Qual Life Outcomes"},{"key":"3915_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.joca.2003.08.010","volume":"12","author":"G Jones","year":"2004","unstructured":"Jones G, Ding C, Scott F, Glisson M, Cicuttini F. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthr Cartil. 2004;12:169\u201374.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR59","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","volume":"22","author":"R Freynhagen","year":"2006","unstructured":"Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911\u201320.","journal-title":"Curr Med Res Opin"},{"key":"3915_CR60","first-page":"685","volume":"3","author":"JK Lee","year":"2007","unstructured":"Lee JK, Grace KA, Foster TG, Crawley MJ, Erowele GI, Sun HJ, Turner PT, Sullenberger LE, Taylor AJ. How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag. 2007;3:685\u201390.","journal-title":"Ther Clin Risk Manag"},{"key":"3915_CR61","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jama.2016.1961","volume":"315","author":"X Jin","year":"2016","unstructured":"Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, Antony B, Wang X, Winzenberg T, Blizzard L, Ding C. Effect of vitamin D supplementation on tibial cartilage volume and knee pain among patients with symptomatic knee osteoarthritis: A randomized clinical trial. JAMA. 2016;315:1005\u201313.","journal-title":"JAMA"},{"key":"3915_CR62","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.joca.2010.08.016","volume":"18","author":"O Stannus","year":"2010","unstructured":"Stannus O, Jones G, Cicuttini F, Parameswaran V, Quinn S, Burgess J, Ding C. Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthr Cartil. 2010;18:1441\u20137.","journal-title":"Osteoarthr Cartil"},{"key":"3915_CR63","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/rheumatology\/kes219","volume":"51","author":"CY Wenham","year":"2012","unstructured":"Wenham CY, Hensor EM, Grainger AJ, Hodgson R, Balamoody S, Dore CJ, Emery P, Conaghan PG. A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis. Rheumatology (Oxford). 2012;51:2286\u201394.","journal-title":"Rheumatology (Oxford)"},{"key":"3915_CR64","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/rheumatology\/kes386","volume":"52","author":"CY Wenham","year":"2013","unstructured":"Wenham CY, Grainger AJ, Hensor EM, Caperon AR, Ash ZR, Conaghan PG. Methotrexate for pain relief in knee osteoarthritis: an open-label study. Rheumatology (Oxford). 2013;52:888\u201392.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3915-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:20:21Z","timestamp":1610479221000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3915-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3915-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.12385\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12385\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12385\/v2","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval has been obtained from the Tasmania Health and Medical Human Research Ethics Committee (H0015465), The Alfred Hospital Ethics Committee (44\/16), Northern Sydney Local Health District Ethics Committee (RESP\/16\/163) and Central Adelaide Local Health Network (CALHN) Human Research Ethics Committee (HREC\/16\/TQEH\/93, Q20160503) and South Metropolitan Health Service Human Research Ethics Committee (2016-035). Written informed consent will be obtained from all patients by the study doctor (i.e., a rheumatologist or supervised rheumatology advanced registrar).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}